Shaily Engineering Plastics Limited has approved the grant of 3,000 stock options to eligible employees under its Shaily Employee Stock Option Plan 2019. The Nomination and Remuneration Committee of the Board of Directors approved the grant at its meeting held on May 19, 2026. The scheme is in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

The total number of shares covered by these options is 3,000 equity shares, each with a face value of ₹2. The options are granted to eligible employees as determined by the committee. The pricing formula for the options is linked to the market price on the date of vesting, with the total value divided into three equal tranches.

Vesting and Exercise Details

The vesting of the options will occur in three equal installments. One-third of the options granted will vest on the completion of one year from the date of grant, the second tranche will vest after two years, and the final tranche will vest after three years. Once vested, the options can be exercised within a period of four years from the date of vesting.

The company noted that the options are yet to be exercised, and consequently, the diluted earnings per share arising from the issue of equity shares is not applicable at this stage. The grant follows a previous approval by shareholders in August 2019, which authorized the issuance of up to 131,570 employee stock options.

ESOP Adjustments

The company also highlighted a recent sub-division of its equity shares. The face value was reduced from ₹10 to ₹2 per share effective November 23, 2023. In view of this sub-division, the total number of options to be granted under the ESOP 2019, including the current grant of 3,000 options, has been augmented proportionally without affecting the rights or obligations of the grantees.

Shaily Engineering Plastics has notified the stock exchanges of an upcoming Board of Directors meeting scheduled for Tuesday, May 19, 2026, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was signed by Company Secretary & Compliance Officer Harish Punwani and dated May 14, 2026.

Key Agenda Items for the Board Meeting

The board meeting has been convened to address several significant corporate matters. The following table outlines the primary agenda items scheduled for consideration:

Fund-Raising Resolution Under Consideration

A notable item on the agenda is the board's consideration of an enabling resolution for capital raising. The permissible modes under review include:

• Private Placement
• Preferential Issue
• Rights Issue
• Qualified Institution Placement (QIP)
• Any other modes as permitted under applicable law

The resolution, if approved, will remain subject to necessary regulatory and statutory approvals, as well as shareholder approval where applicable.

Trading Window Closure

In accordance with the company's "Code of Internal Procedure and Conduct of Regulating, Monitoring and Reporting of Trading in Securities by Insiders" and SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window has been closed for all persons covered under the Code. The closure period is as follows:

The trading window will remain shut until 48 hours after the declaration of the audited financial results, effectively keeping it closed through May 21, 2026.